These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25194471)

  • 41. Disease-specific direct-to-consumer advertising for reminding consumers to take medications.
    Bhutada NS; Rollins BL
    J Am Pharm Assoc (2003); 2015; 55(4):434-7. PubMed ID: 26161486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of celebrity pitch in direct-to-consumer advertising of prescription drugs.
    Bhutada NS; Menon AM; Deshpande AD; Perri M
    Health Mark Q; 2012; 29(1):35-48. PubMed ID: 22416924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of benefit data in direct-to-consumer drug ads.
    Woloshin S; Schwartz LM; Welch HG
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-234-45. PubMed ID: 15452006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation.
    O'Donoghue AC; Johnson M; Sullivan HW; Parvanta S; Ray S; Southwell BG
    J Health Commun; 2019; 24(4):368-376. PubMed ID: 31012394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.
    Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Aikin KJ
    J Health Commun; 2017 Feb; 22(2):171-181. PubMed ID: 28129069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The educational potential of direct-to-consumer prescription drug advertising.
    Kaphingst KA; DeJong W
    Health Aff (Millwood); 2004; 23(4):143-50. PubMed ID: 15318574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of health warnings for sugar-sweetened beverages on consumer perceptions of advertising.
    Hammond D; Acton RB; Goodman S
    Public Health Nutr; 2021 Oct; 24(14):4737-4749. PubMed ID: 33843566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
    Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
    Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.
    Eisenberg MD; Singh Y; Sood N
    JAMA Health Forum; 2022 Aug; 3(8):e222570. PubMed ID: 36200632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct-to-consumer ads can influence behavior. Advertising increases consumer knowledge and prescription drug requests.
    Peyrot M; Alperstein NM; Van Doren D; Poli LG
    Mark Health Serv; 1998; 18(2):26-32. PubMed ID: 10180332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prescription drug advertising: is it a driving force on drug pricing?
    Millstein LG
    N C Med J; 2003; 64(6):289-91. PubMed ID: 14983621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease-specific direct-to-consumer advertising of pharmaceuticals: An examination of endorser type and gender effects on consumers' attitudes and behaviors.
    Bhutada NS; Rollins BL
    Res Social Adm Pharm; 2015; 11(6):891-900. PubMed ID: 25797861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effect of Comparatively-Framed versus Similarity-Framed E-Cigarette and Snus Print Ads on Young Adults' Ad and Product Perceptions.
    Banerjee SC; Greene K; Li Y; Ostroff JS
    Tob Regul Sci; 2016 Jul; 2(3):214-229. PubMed ID: 28042597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Awareness of and attitudes toward direct-to-consumer prescription drug advertising among young adults.
    Alperstein NM
    Health Mark Q; 2014; 31(3):231-45. PubMed ID: 25120044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct-to-consumer prescription drug advertising and the public.
    Bell RA; Kravitz RL; Wilkes MS
    J Gen Intern Med; 1999 Nov; 14(11):651-7. PubMed ID: 10571712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications.
    Viale PH; Sanchez Yamamoto D
    Oncol Nurs Forum; 2004 Jul; 31(4):777-83. PubMed ID: 15252431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Message strategies in direct-to-consumer pharmaceutical advertising: a content analysis using Taylor's six-segment message strategy wheel.
    Tsai WH; Lancaster AR
    Health Mark Q; 2012; 29(3):239-55. PubMed ID: 22905945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attention to and Distraction from Risk Information in Prescription Drug Advertising: An Eye Tracking Study.
    Sullivan H; Boudewyns V; O'Donoghue A; Marshall S; Williams PA
    J Public Policy Mark; 2017 Sep; 36(2):236-245. PubMed ID: 33505105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Consumer's Regulatory Knowledge of Prescription Drug Advertising and Health Risk Awareness: The Moderating Role of Risk Information Prominence.
    Ju I; Ohs JE; Park JS
    Health Commun; 2020 May; 35(6):696-706. PubMed ID: 30835557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Do dissonant ad visuals cause consumers to discount prescription drug side effects?
    Hagenbuch D
    Health Mark Q; 2019; 36(4):337-353. PubMed ID: 31646956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.